Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
作者信息
Conter Valentino, Ceppi Francesco
机构信息
Pediatric Hemato-Oncology, Fondazione MBBM, University Milano Bicocca, Ospedale San Gerardo, Monza, Italy.
Pediatric Hematology-Oncology Unit, Division of Pediatrics, Department Woman-Mother-Child, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.
出版信息
Haematologica. 2022 Feb 1;107(2):356-357. doi: 10.3324/haematol.2021.279059.
Abstract
摘要
相似文献
1
Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?儿童急性淋巴细胞白血病还需要进行临床药理学研究吗？
Haematologica. 2022 Feb 1;107(2):356-357. doi: 10.3324/haematol.2021.279059.
2
[Childhood acute lymphoblastic leukemia (ALL)].[儿童急性淋巴细胞白血病（ALL）]
Rinsho Ketsueki. 2013 Jan;54(1):100-8.
3
Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.儿童急性淋巴细胞白血病细胞遗传学研究的临床意义：柏林-法兰克福-明斯特方案（BFM）试验经验
Recent Results Cancer Res. 1993;131:123-32. doi: 10.1007/978-3-642-84895-7_12.
4
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005.第七届国际儿童急性淋巴细胞白血病研讨会报告：意大利巴勒莫，2005年1月29日至30日。
Leukemia. 2005 Jul;19(7):1145-52. doi: 10.1038/sj.leu.2403783.
5
[Childhood acute lymphoblastic leukemia; pathophysiology and treatment strategy].[儿童急性淋巴细胞白血病；病理生理学与治疗策略]
Rinsho Ketsueki. 2013 Nov;54(11):2038-46.
6
International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000.
Leukemia. 2001 May;15(5):707-15. doi: 10.1038/sj.leu.2402111.
7
Pharmacogenetics of childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病的药物遗传学
Pharmacogenomics. 2014 Jul;15(10):1383-98. doi: 10.2217/pgs.14.106.
8
Pharmacology and drug resistance in childhood lymphoblastic leukemia.
Hematol Oncol Clin North Am. 1990 Oct;4(5):871-94.
9
Pharmacogenetics of acute lymphoblastic leukemia treatment response.急性淋巴细胞白血病治疗反应的药物遗传学
Expert Opin Pharmacother. 2007 Oct;8(15):2519-31. doi: 10.1517/14656566.8.15.2519.
10
CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.CREBBP基因敲低增强了Ras通路突变的急性淋巴细胞白血病中的RAS/RAF/MEK/ERK信号传导，但不调节化疗反应。
Haematologica. 2017 Apr;102(4):736-745. doi: 10.3324/haematol.2016.145177. Epub 2016 Dec 15.
本文引用的文献
1
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy.急性淋巴细胞白血病化疗剂量强度的综合分析。
Haematologica. 2022 Feb 1;107(2):371-380. doi: 10.3324/haematol.2021.278411.
2
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.强化诱导治疗联合克拉屈滨治疗新诊断高危 B 淋巴细胞白血病极高危层患者的相关毒性：来自儿童肿瘤协作组 AALL1131 研究的报告。
Cancer. 2018 Mar 15;124(6):1150-1159. doi: 10.1002/cncr.31099. Epub 2017 Dec 19.
3
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.NOPHO ALL2008 方案治疗 1-45 岁急性淋巴细胞白血病患者的结果。
Leukemia. 2018 Mar;32(3):606-615. doi: 10.1038/leu.2017.265. Epub 2017 Aug 18.
4
Prolonged standard native asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951.EORTC-CLG 随机 III 期试验 58951 研究：儿童急性淋巴细胞白血病和非霍奇金淋巴瘤中延长标准天然门冬酰胺酶治疗的最终结果。
Haematologica. 2017 Oct;102(10):1727-1738. doi: 10.3324/haematol.2017.165845. Epub 2017 Jul 27.
5
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.多种族急性淋巴细胞白血病儿童队列中6-巯基嘌呤的依从性：一项儿童肿瘤学组的研究。
Blood. 2014 Oct 9;124(15):2345-53. doi: 10.1182/blood-2014-01-552166. Epub 2014 May 14.
6
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.在基于柏林-法兰克福-明斯特方案的治疗中，第二次给予长时间高剂量L-天冬酰胺酶的效果：随机9102中危儿童急性淋巴细胞白血病研究结果——来自意大利儿科学血液学肿瘤学协会的报告
J Clin Oncol. 2001 Mar 1;19(5):1297-303. doi: 10.1200/JCO.2001.19.5.1297.
7
8
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.强化柏林-法兰克福-明斯特方案治疗消除了急性淋巴细胞白血病伴不良特征的儿童和青少年对诱导化疗早期反应缓慢的不良预后意义：儿童癌症小组报告
J Clin Oncol. 1997 Jun;15(6):2222-30. doi: 10.1200/JCO.1997.15.6.2222.
9
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.
Haematol Blood Transfus. 1990;33:459-66. doi: 10.1007/978-3-642-74643-7_83.
10
Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.儿童急性淋巴细胞白血病两种强化治疗方案的比较结果：柏林-法兰克福-明斯特方案与达纳-法伯癌症研究所方案
Ann Oncol. 1991 Nov-Dec;2(10):745-9. doi: 10.1093/oxfordjournals.annonc.a057856.
Zotero 插件